Cargando…
The Potential Influence of Advanced Glycation End Products and (s)RAGE in Rheumatic Diseases
Advanced glycation end products (AGEs) are a class of compounds formed by nonenzymatic interactions between reducing sugars and proteins, lipids, or nucleic acids. AGEs can alter the protein structure and activate one of their receptors, specifically the receptor for advanced glycation end products...
Autores principales: | Delrue, Charlotte, Speeckaert, Reinhart, Delanghe, Joris R., Speeckaert, Marijn M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918052/ https://www.ncbi.nlm.nih.gov/pubmed/36769213 http://dx.doi.org/10.3390/ijms24032894 |
Ejemplares similares
-
The Role of Advanced Glycation End Products and Its Soluble Receptor in Kidney Diseases
por: Steenbeke, Mieke, et al.
Publicado: (2022) -
The Role of Vitamin D in Diabetic Nephropathy: A Translational Approach
por: Delrue, Charlotte, et al.
Publicado: (2022) -
Vitamin D Deficiency: An Underestimated Factor in Sepsis?
por: Delrue, Charlotte, et al.
Publicado: (2023) -
Potential underlying mechanisms of cerebral venous thrombosis associated with COVID-19
por: Speeckaert, Marijn M., et al.
Publicado: (2020) -
Vitamin D Sufficiency and COVID-19: Is Vitamin D Binding Protein (and Its Polymorphism) the Missing Link?
por: Speeckaert, Marijn M., et al.
Publicado: (2021)